Unrecognized Tax Benefits in USD of Eiger BioPharmaceuticals, Inc. from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and change rate from Q4 2012 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2023 was $5.28M, a 51.1% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5.28M +$1.78M +51.1% 31 Dec 2023 10-K 08 Apr 2024
Q4 2022 $3.49M +$1.54M +79.1% 31 Dec 2022 10-K 08 Apr 2024
Q4 2021 $1.95M +$1.5M +332% 31 Dec 2021 10-K 08 Apr 2024
Q4 2020 $451K -$2.83M -86.2% 31 Dec 2020 10-K 17 Mar 2023
Q4 2019 $3.28M -$1.36M -29.3% 31 Dec 2019 10-K 17 Mar 2023
Q4 2018 $4.63M +$1.42M +44% 31 Dec 2018 10-K 10 Mar 2022
Q4 2017 $3.22M +$1.39M +75.8% 31 Dec 2017 10-K 09 Mar 2021
Q4 2016 $1.83M +$1.43M +353% 31 Dec 2016 10-K 13 Mar 2020
Q4 2015 $404K +$305K +308% 31 Dec 2015 10-K 14 Mar 2019
Q4 2014 $99K +$2K +2.06% 31 Dec 2014 10-K 09 Mar 2018
Q4 2013 $97K +$2K +2.11% 31 Dec 2013 10-K 23 Mar 2017
Q4 2012 $95K 31 Dec 2012 8-K/A 17 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.